ROCKVILLE, Md., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the “Company”), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company will participate in the Rodman & Renshaw 13th Annual Global Investment Conference taking place September 12-13, 2011 at the Waldorf Astoria Hotel in New York City.
